Post by importservice on Sept 14, 2021 3:01:42 GMT -5
Adcetris is an anti-cancer agent used to treat patients with relapsed or refractory Hodgkin lymphoma (HL) and systemic anaplastic large cell lymphoma (ALCL), which is a type of T-cell non-Hodgkin lymphoma. The standard dose of Adcetris should be given as an intravenous infusion over 30 minutes every 3 weeks. The adcetris 50 mg should be administered under the supervision of a doctor experienced in the use of anti-cancer agents.